HealthCap is a specialized venture capital firm investing globally in life sciences, focusing on breakthrough therapeutics for diseases with high unmet medical need. Founded in 1996, the firm has raised over €1.2 billion across nine funds and is headquartered in Stockholm, Sweden with an office in Lausanne, Switzerland.
Average disclosed round size is $62.2M (across 55 rounds with reported amounts).
Portfolio
50
Fund Size
—
Top Stage
Series A
Last 12 Mo
6
Team
Mårten Steen
Managing Partner | MD PhD
Carl-Johan Dalsgaard
Venture Partner | MD PhD
Eugen Steiner
Venture Partner | MD PhD
Georg Vo Beiske
Venture Partner | MSc
Johan Christenson
Partner | MD PhD
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
86 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| PPrecirix | Series B | — | Aug 2026 |
 CurifyLabs | Series A | $14M | Jul 2026 |
 Adcendo ApS | Series C | $75M | Apr 2026 |
| CurifyLabs | Unknown | — | Feb 2026 |
 Tribune Therapeutics | Series A | — | Jan 2026 |
| CurifyLabs | Series A | $14M | Jan 2026 |
| HHemab | Series C | $157M | Oct 2025 |
| Tribune Therapeutics | Series A | — | Apr 2025 |
| CurifyLabs | Unknown | $6.7M | Jan 2025 |
 Gensight Biologics | Series B | — | Jan 2025 |
 Intervacc | Unknown | — | Dec 2024 |
| Adcendo ApS | Series B | $135M | Nov 2024 |
| SSynox Therapeutics | Pre-Seed | $92M | Oct 2024 |
 KIVU BIOSCIENCE | Series A | $92M | Oct 2024 |
| SSynox Therapeutics | Series B | $75M | Apr 2024 |
 Modus Therapeutics | Bridge | — | Jan 2024 |
| Adcendo ApS | Series B | $135M | Jan 2024 |
 Aro Biotherapeutics | Series B | $41.5M | Nov 2023 |
| RRampart Biosciences | Series A | $85M | Oct 2023 |
| AAriceum Therapeutics | Unknown | — | Apr 2023 |
| HHemab Therapeutics Holdings | Series B | $135M | Feb 2023 |
| HHemab | Series B | $135M | Feb 2023 |
| RRampart Bio | Series A | $85M | Jan 2023 |
 Pretzel Therapeutics | Series A | $72.5M | Sep 2022 |
 Ariceum | Series A | — | Jun 2022 |
Page 1 of 4
Top Co-Investors
Novo Capital15 shared
RA Capital Management14 shared
Novo Holdings A/S13 shared
TPG Biotech10 shared
OrbiMed10 shared
Forbion9 shared
Ysios Capital9 shared
Pontifax8 shared
Rock Springs Capital8 shared
Gimv7 shared
Sofinnova Partners7 shared
Gilde Healthcare7 shared
The Invus Group, LLC6 shared
Surveyor Capital6 shared
MRL Ventures Fund5 shared
Wellington Management5 shared
Agent Capital5 shared
Jeito Capital5 shared
Industrifonden5 shared
Dawn Biopharma5 shared
Last updated: 20 October 2026